Hallucinogenic Drugs - PowerPoint PPT Presentation

1 / 52
About This Presentation
Title:

Hallucinogenic Drugs

Description:

Hallucinogenic Drugs Drugs that create unusual perceptual and cognitive distortions Many different names Psychotomimetic (psychosis mimicking) not used these days – PowerPoint PPT presentation

Number of Views:239
Avg rating:3.0/5.0
Slides: 53
Provided by: usersIpfw9
Category:

less

Transcript and Presenter's Notes

Title: Hallucinogenic Drugs


1
  • Hallucinogenic Drugs
  • Drugs that create unusual perceptual and
    cognitive distortions
  • Many different names
  • Psychotomimetic (psychosis mimicking)
  • not used these days
  • Drugs no longer considered a model for psychosis
  • Psychedelic (mind opening)
  • Sometimes the term used by those that use the
    drug class
  • Hallucinogenic (hallucination producing)
  • Modern pharmacological literature uses this term

2
  • Mescaline
  • Obtained from the peyote cactus plant
  • Dried crown of the plant is know as a mescal
    button, or peyote button.
  • Buttons can be chewed raw or cooked and then
    eaten
  • It is also possible to extract the mescaline from
    the plant and create a relatively pure powder

3
  • Archeological evidence suggests that natives of
    Southwestern United States and Northern Mexico
    Have used for thousands of years
  • Native Americans used peyote for religious and
    healing rituals
  • Aldous Huxley (Brave New World)
  • Used mescaline and advocated use of hallucinogens
  • Some consider his writings about the experiences
    of hallucinogens to have spawned the rise of
    their popularity in the 1960s
  • The Doors of Perception
  • Heaven and Hell
  • Mescaline is not as readily available in present
    times as other hallucinogens

4
Psilocybin, DMT, and 5-MeO-DMT
  • Shrooms or Magic Mushrooms
  • Numerous species of mushrooms have hallucinogenic
    properties
  • Psilocybe mushrooms ?
  • Depending on the species, users take about 1-5 g
    of dried mushrooms to obtain desired effects
  • Can be consumed raw, boiled in water to make tea,
    or cooked with other foods
  • Tends to be bitter alone

5
  • The major ingredient of mushrooms are psilocybin
    and the related compound psilocin
  • Psilocin is the actual psychoactive agent
  • Psilocybin is converted by enzymatic action to
    psilocin after ingestion
  • Use of hallucinogenic mushrooms probably goes as
    far back as peyote use
  • Algerian painting dated to at least 3500 B.C.
  • Shaman?
  • Notice mushrooms sprouting from entire body and
    held in hands

6
  • The Spaniards tried to suppress the use of
    mushrooms when they conquered the Aztecs in the
    early 1500s
  • They were not completely successful
  • The existence of hallucinogenic mushrooms was
    largely ignored until the 1950s and 60s
  • Timothy Leary lecturer at Harvard ate magic
    mushrooms while visiting Mexico in 1959
  • Formed the Harvard Psychedelic Drug Research
    Program
  • Purpose was to teach individuals how to
    self-administer psychoactive drugs in order to
    free their psyches without reliance upon doctors
    or institutions
  • Gave psilocybin to students and faculty
  • Also experimented with LSD
  • Dismissed from Harvard in 1963
  • Became leader in psychedelic movement

7
DMT and 5-MeO-DMT
  • DMT and 5-MeO-DMT are substances found in several
    plants indigenous to South America
  • Native tribes make hallucinogenic snuffs from
    these plants
  • DMT in this country is usually sold in powdered
    form and taken by smoking
  • Synthetic analogs have been gaining popularity
  • ?-methyltryptramine (AMT)
  • 5-methoxy-diisopropyltryptamine
  • Foxy Methoxy or Foxy

8
LSD
  • LSD is a synthetic compound
  • Its structure is based on a family of fungal
    alkaloids
  • Alkaloids are chemical compounds containing
    nitrogen that have psychopharmacological effects
  • often found in plants and fungi

9
LSD first synthesized in 1938
  • Albert Hofmann
  • Worked for a pharmaceutical company in
    Switzerland (Sandoz)
  • Studying ergot
  • a substance produced by a parasitic fungus that
    can infest rye and wheat
  • Ergot is extremely toxic to humans
  • A core structure of the alkaloids contained in
    ergot is lysergic acid
  • Hofmann combined lysergic acid with other
    compounds in an attempt to generate drugs to
    stimulate the circulatory system

10
LSD-25 (LSD)
  • The 25th compound synthesized was d-lysergic acid
    diethylamide
  • LSD-25
  • Hoffman accidentally ingested some and had
    strange sensations
  • Later he took a small amount on purpose
  • Had powerful effects
  • Sandoz marketed the drug in 1947
  • Delysid
  • To help neurotic patients uncover repressed
    thoughts and feelings

11
  • In the 50s and 60s there were a lot of studies
    published on the effects of LSD
  • The fact that LSD altered serotonergic activity
    led many researchers to consider this a powerful
    tool to understand human mental activity and
    behavior
  • Some considered the drug psychotomimetic
  • Perhaps could be a model for a schizophrenia
  • Replaced now by PCP and Ketamine
  • Some considered LSD to be an aid to psychotherapy
  • Psycholytic therapy (Europe)
  • Psychic loosening or opening
  • Release repressed memories and enhance
    communication with the therapist
  • Psychedelic therapy (US, Canada, Britain)
  • Give LSD to patient to help them gain insight
    through a drug-induced spiritual experience

12
  • US government explored the possibilities of LSD
    as a psychological weapon
  • MK-ULTRA (CIA program)
  • Designed to investigate LSD as a mind control
    agent
  • At one point they gave LSD to unsuspecting
    members of the public to observe behavioral
    reactions.
  • http//soundmedicine.iu.edu/segment.php4?seg1644
  • Check out the above link for a segment from NPRs
    Sound Medicine that discusses MK-ULTRA

13
  • As you know LSD was extremely popular in the
    hippie culture of the 1960s
  • There was a backlash against its use
  • Federal laws in 1965 restricted new research on
    LSD
  • Sandoz stopped distributing LSD for research
    purposes
  • Recreational use of LSD was banned in 1967
  • There has been a resurgence in the interest in
    LSD research recently

14
  • LSD is usually taken orally
  • A single dose of LSD in crystalline form is
    barely visible to the naked eye
  • Larger amounts of LSD are dissolved in water and
    then droplets are applied to a sheet of paper and
    dried (a blotter)
  • Individual squares of the blotter are sold as a
    single dose tabs

15
Potency and time course of action of
Hallucinogenic Drugs
  • The potency of hallucinogenic drugs vary
  • Most are taken orally, but as mentioned earlier
    DMT is usually smoked
  • For the drugs taken orally onset of effects
    usually takes 30-90 minutes
  • The trip can take 6-12 hours
  • Psilocybin maybe less
  • The effects of smoked DMT are felt within
    seconds. Peak effects occur within 5-20 minutes
  • Effects are over in an hour or less
  • businessmans trip

16
Psychological and physiological response to
hallucinogenics
  • Similar across different forms
  • Text focuses on LSD
  • Four phases of the trip
  • Onset - 30 minutes to an hour after ingestion
  • Visual effects
  • Intensification of colors
  • Appearance of geometric patterns and strange
    objects can be seen with eyes closed
  • Plateau phase next 2 hours or so
  • Sense of time begins to slow
  • Visual effects become more intense

17
  • Peak phase about 3 hours into trip lasts
    another 2 or 3 hours
  • May feel like in another world in which time has
    been suspended
  • Continuous stream of bizarre distorted images
  • Can be beautiful, or menacing
  • May experience synesthesia
  • Crossing over of senses colors heard
  • Come down phase 2 more hours or so
  • Most effects are gone by the end
  • User may not feel completely normal until the
    next day

18
  • hallucinogens can produce other psychological
    effects in addition to the phases of
    sensory-perceptual effects above
  • Emotional shifts
  • Euphoria
  • Anxiety
  • Fear
  • Feelings of depersonalization
  • Being outside oneself
  • Disruption of logical thought

19
  • Sometimes the LSD experience is viewed as
    mystical or spiritually enlightening
  • Good trip
  • Sometimes it can be disturbing and frightening
  • Bad trip
  • Good trip or bad trip may depend in part on
  • The dose
  • Individuals personality
  • Expectations
  • Previous experience
  • Social setting
  • Cant really predict the outcome of an LSD trip
    in advance

20
Physiological response to hallucinogens
  • LSD effects reflect activation of the sympathetic
    response
  • Pupil dilation
  • Increased
  • Heart rate
  • Blood pressure
  • Body temperature
  • Can cause
  • Dizziness
  • Nausea
  • Vomiting
  • These effects are more likely with peyote and
    psilocybin

21
Indoleamine hallucinogens
  • Most hallucinogens have either a serotonin-like
    or a catecholamine-like structure
  • Serotonin-like or indolamine hallucinogens
  • LSD, Psilocybin, psilocyn, DMT, 5-MeO-DMT,
    synthetic tryptamines

22
Phenethylamine hallucinogens
  • Catecholamine-like hallucinogens
  • Notice their similarity to Norepinephrine
  • of course they are also structurally similar to
    DA
  • Remember Amphetamine chapter
  • Mescaline is the catecholamine-like hallucinogen
    that we have discussed
  • but there are also forms of amphetamines that
    have hallucinogenic properties
  • DOM
  • TMA
  • Together these drugs are known as phenethylamine
    hallucinogens

23
Hallucinogens are 5-HT2 receptor agonists
  • How hallucinogens cause dramatic cognitive and
    perceptual effects is not well understood
  • Evidence for serotonergic effects
  • LSD binds with high affinity to multiple
    serotonergic receptor subtypes
  • 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C, 5-HT5A, 5-HT6,
    5-HT7

24
  • If we compare the indolamine and phenethylamine
    hallucinogen families we find that both bind to
    only a couple of serotonin receptor subtypes
  • 5-HT2A and 5-HT2C
  • This suggests those receptor subtypes may play a
    key role

25
  • There is not a lot of human experimental work on
    the hallucinogens
  • Here is 1 nice study
  • Vollenweider et al. (1998) studied psilocybin.
  • Found that visual illusions and hallucinations
    produced by these drugs were blocked by
    antagonists of the 5-HT2A receptor.
  • Ketanserin
  • Risperidone
  • Also blocks D2 receptors
  • Note in next graph that haloperidol (another D2
    antagonist) did not block these effects
  • Ruling out D2 effects

26
14.7 Blockade of psilocybin-induced visual
illusions and hallucinations
27
  • Since there is not a lot of human work, animal
    studies are very important.
  • Drug discrimination studies are quite useful here
  • Train to discriminate LSD from saline injection
  • LSD lever
  • Saline lever

28
  • Then the animals were tested with various doses
    of particular 5-HT2A receptor antagonists
  • Notice all 3 antagonists decreased responding to
    The LSD lever.
  • Switched to saline lever
  • Implies these antagonists blocked the subjective
    effects of LSD
  • Drugs that have higher affinity for 5-HT2A do a
    better job of blocking these effects

29
Tolerance
  • Most hallucinogenic drugs cause rapid tolerance
    with repeated use
  • Humans taking LSD for 4 days showed nearly
    complete tolerance by day 4
  • Likely the result of down regulation of 5-HT2A
    receptors
  • A 2005 study with mice showed down regulation of
    5-HT2A receptors after repeated LSD exposure
  • Takes 3 or 4 days for tolerance to go away

30
Neural Mechanisms of hallucinations
  • One theory is that the locus coeruleus plays an
    important role
  • Remember- dense cluster of NE neurons in the pons
  • Receives information from all the major sensory
    systems and sends that information to all areas
    of the cortex.

31
Neural Mechanisms of hallucinations
  • Aghajanian et al found that LSD and mescaline
    decreased spontaneous firing of neurons in the
    rat LC
  • However, they also found that the LC cells were
    more easily excited by sensory information
  • Put together, these effects make the LC far more
    sensitive to sensory input.
  • Baseline is lowered
  • Responsivity increased

32
Neural Mechanisms of hallucinations
  • Perhaps the increased sensitivity of the LC is
    the mechanism of perceptual distortion and
    hallucination following ingestion of LSD
  • Studies using fMRI with shizophrenic patients
    experiencing hallucinations show increased
    activity in cortical regions that normally code
    that sense
  • Visual occipital
  • Auditory temporal

33
  • Other researchers posit that areas such as the
    prefrontal cortex, striatum, and thalamus (fronto
    sub-cortical circuits) might serve as a gating
    mechanism for sensory information.
  • The idea is that the hallucinogens may open the
    gate, thus, flooding the cortex with information
  • These researchers believe that this might also
    explain the cognitive disturbances common with
    hallucinogenic drugs as well

34
Addiction?
  • Hallucinogens are not considered addictive
  • People usually do not binge
  • Do not cause cravings
  • Do not cause physical dependence or withdrawal
  • Do not support self-administration in animals
  • Doesnt seem possible to overdose
  • No documented human deaths
  • Eight individuals have been documented as taking
    massive doses
  • Snorted crystaline form (mistaken for cocaine)
  • Remember a barely visual grain is psychoactive
  • Comatose state
  • Vomiting
  • Hyperthermia
  • Light gastric bleeding
  • Respiratory problems
  • They all survived without residual effects

35
  • Despite lack of addictive potential and lack of
    overdose issues, the use of LSD can have
    consequences
  • Bad trips
  • Flashbacks
  • Hallucinogen persisting perception disorder
    (HPPD)
  • Long lasting flashbacks causing major impairment
    or disturbance
  • Few documented cases
  • Psychotic breakdown?
  • Prolonged psychotic episodes following LSD use
    invariably involve individuals
  • Already diagnosed with a psychiatric disorder
  • That exhibited prepsychotic symptoms prior to
    taking the drug

36
PCP and Ketamine
  • PCP and ketamine were both initially developed as
    anesthetics.
  • PCP
  • 1-(1-phenylcyclohexyl) piperdine
  • AKA phencylclidine
  • Developed in the 1950s as an anesthetic
  • Produced unusual anesthesia
  • No responsiveness to nociceptive stimuli
  • But, not typical relaxed unconsciousness (like
    seen with barbiturates).
  • Trance-like or catatonic-like state
  • Vacant expression
  • Fixed staring eyes
  • Maintenance of muscle tone
  • Not uncommon to have rigidity or waxy flexibility
    like seen in catatonic schizophrenics

37
  • PCP was initially considered a promosing
    anesthetic
  • Did not produce respiratory depression like seen
    with barbiturates
  • High therapeutic index
  • But some patients had problematic reactions
  • Agitation rather than quieting
  • Postoperative effects ranging from blurred
    vision, dizziness, and mild disorientationto
    hallucinations, severe agitation, and violence.
  • Clinical use of PCP was terminated in 1965

38
  • PCP became a more popular illicit drug in 1967.
  • AKA Angel dust hog
  • Never was as popular as marijuana or even cocaine
    or heroin

39
  • Ketamine was developed as a safer alternative to
    PCP
  • First synthesized in 1962
  • CI-581 ---- later renamed ketamine
  • Less potent and shorter acting than PCP
  • Valuable anesthetic particularly for children
  • Also animals
  • Currently available with prescription
  • Ketaset
  • Ketalar
  • Vetalar

40
Route of administration
  • PCP is generally obtained in powder form
  • Can be ingested by any common route
  • Orally
  • Intranasally
  • IV
  • IM
  • Smoked
  • Applied as a liquid to a cigarette

41
Route of administration
  • Ketamine is marketed as an injectable liquid
  • Street sellers commonly evaporate the liquid to
    yield a powder.
  • Can be snorted
  • Compressed into a pill
  • AKA K, special K, and cat valium.

42
  • Studies form the 50s and 60s found that
    subanesthetic doses of PCP produce
  • Feeling of being detached from body
  • Dissociation
  • Sensations of vertigo or floating, numbness.
  • Dream like state
  • Affective changes
  • Drowsiness, apathy, negativism
  • Sometimes hostility toward experimenters
  • Sometimes euphoria
  • Cognitive disorganization
  • Difficulty maintaining concentration
  • Deficiency in abstract thinking
  • Halting speech

43
Subjective effects of ketamine
  • Low doses of ketamine produce reactions similar
    to what occurs with PCP
  • High doses can produce dissociative anesthesia
  • Lose mental contact with environment for 10
    minutes or so
  • Eyes open
  • Maintain muscle tone
  • Some have described the dissocative state as a
    near-death experience
  • Sometimes called K-hole
  • Sometimes spiritually uplifting
  • Sometimes terrifying

44
(No Transcript)
45
Reinforcement
  • PCP and ketamine support self-administration in
    several species
  • Rhesus monkeys self-administered PCP at levels to
    maintain continuous intoxication
  • Could not stand up.
  • Lying or sitting on floor near lever
  • PCP and ketamine activate midbrain DA cell
    firing.
  • Stimulate DA release particularly in prefrontal
    cortex
  • Rats will self-administer PCP directly in the NA
  • This affect may be driven by inhibition of
    glutamatergic input to the NA rather affecting
    the DA system

46
PCP and Ketamines action at the NA
  • Cocaine and amphetamine are indirect DA agonists
  • DA normally inhibits NA
  • Slowing NA activity reinforcement
  • PCP and ketamine are antagonists of Glutamate (at
    NMDA receptor)
  • Glutamate normally excites NA
  • Slowing NA activity reinforcement

47
14.12 Self-administration of PCP into the
nucleus accumbens shell by rats (Part 1)
48
PCP and ketamine are noncompetitive antagonists
of the NMDA receptor
  • NMDA is an ionotropic receptor that responds to
    glutamate
  • NMDA and ketamine block at the receptor by
    binding to a site different from where glutamate
    binds
  • Making them noncompetitive antagonists
  • Remember the binding site is inside the channel
  • NMDA receptors found throughout the brain
    including the cerebral cortex and hippocampus
  • This probably leads to the cognitive deficits

49
  • The use of ketamine seems to be increasing
  • Studies of ketamine use indicate that it can
    cause strong addiction
  • People also take increasing doses indicating
    tolerance

50
Model of schizophrenia
  • Acute PCP or ketamine exposure causes perceptual,
    cognitive, and affective responses closely
    resembling symptoms of schizophrenia
  • Can cause positive and negative symptoms
  • Positive
  • Hallucinations
  • Bizarre thought content
  • Negative
  • Blunted affect
  • Emotional withdrawal
  • Slowed motor response
  • Some of the symptoms can persist for days
  • Perceptual distortion
  • Magical ideation

51
  • Animal models
  • Evidence that chronic PCP administration can
    cause lasting deficits that mimic some symptoms
    of schizophrenia
  • Show deficits on tasks that require prefrontal
    cortex function

52
14.13 Ketamine administration produces a
dose-dependent increase in psychotic-like symptoms
Write a Comment
User Comments (0)
About PowerShow.com